RNA vaccines

As many as 5,643 doses of Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccine have been administered in the last 24 hours, of which 3,406 are the first dose and 2,237 the second dose, according to a report released Sunday by the National Committee of Coordination Activities against COVID-19 (CNCAV).

A new study out of the UK has shown that the effectiveness of the Pfizer/BioNTech vaccine is waning faster than others when up against a high viral load mutation of the coronavirus, like the Delta variant

Israelis aged 40 and over will be able to receive coronavirus vaccine booster shots starting this weekend, Health Minister Nitzan Horowitz said on Aug. 19, as the country battles a spike in infections.

class='cf'>

The European Union will accept Turkish COVID-19 certificates as of Aug. 20, the European Commission announced on on Aug. 19. 

class='cf'>

The EU executive body adopted equivalence decisions for the COVID-19 certificates issued by the authorities of Turkey, North Macedonia, and Ukraine.

A third dose of a COVID-19 vaccine offers better protection against the coronavirus, Turkey's Health Minister Fahrettin Koca has said, urging people to get the booster shot.

As many as 15,260 vaccine doses from Pfizer, Moderna, AstraZeneca and Johnson&Johnson were administered in the last 24 hours, of which 10,831 represent the first dose, and 4,429 the second dose, according to a briefing sent on Wednesday by Romania's National COVID-19 Vaccination Coordination Committee (CNCAV).

Over the past month, Israel, the world's most heavily vaccinated country (with leading mRNA jabs, no less) has seen the number of positive COVID tests has risen by more than 30x as the number of active infections in the country has surpassed 10,000.

The efficacy of the Pfizer/BioNTech coronavirus vaccine fell from 96% to 84% after six months, a new preprint report by medRxiv showed on Wednesday.

Head of the National COIVID-19 Vaccination Coordination Committee (CNCAV) Valeriu Gheorghita said on Tuesday in September there will very likely be a decision on the administration of a third dose of COVID-19 vaccine to people at high risk of exposure, such as the healthcare workers, people with chronic diseases, those over 65 years of age.

Turkey has started to administer its homegrown COVID-19 vaccine candidate to volunteers at a major hospital in the capital Ankara as part of the jab's Phase 3 clinical trials to compare its efficacy to that of the Chinese-developed CoronaVac shot, the country's top health official announced on July 16.